-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Functional Screening for Precision Medicine Approaches in Acute Myeloid Leukemia.

Program: Scientific Symposia
Session: Multi-Omics Driven Precision Hematology
Monday, December 11, 2023, 2:45 PM-4:00 PM

Mika Kontro, MD, PhD

Helsinki University Hospital and University of Helsinki, Helsinki, Finland

Disclosures: Kontro: Servier: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Astellas: Consultancy, Membership on an entity's Board of Directors or advisory committees; Pfizer: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Novartis: Membership on an entity's Board of Directors or advisory committees; BMS: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; AbbVie: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Faron Pharmaceuticals: Consultancy; Immedica: Membership on an entity's Board of Directors or advisory committees.

OffLabel Disclosure:

See more of: Multi-Omics Driven Precision Hematology
See more of: Scientific Symposia
<< Previous Presentation | Next Presentation >>